Find out more ways to treat psoriasis in the future

Published Date: 02 Mar 2023

According to MBA MD Andrew Blauvelt, the development of oral biologics and early treatment to replace the disease is a possibility.

Read Full News

Latest News

US FDA Reverses Course on Regenxbio's Rare-disease Gene Therapy, Backs Accelerated Approval Bid

Regenxbio said on Monday the U.S. FDA has indicated that existing data for its rare-disease gene therapy could support ⁠an accelerated approval application, reversing course...

Geographic and Income Data Missing From Cancer Trial Reports

Researchers conducted a systematic review of 441 US-based randomized cancer treatment trials to see what patient characteristics were reported.

Can Printed ‘Skin’ Help to Heal Burns Without Scars?

Inks created with a patient’s own cells may one day help the body regrow tissues.

Down Syndrome: Skin Conditions That Demand Attention

Psoriasis, hidradenitis suppurativa, alopecia areata, and other skin conditions are more common in people with Down syndrome and require multidisciplinary, mechanism-specific management, experts say.

Nicotinamide Cost-Effective for Reducing KC Risk

The study in US veterans found that oral nicotinamide was 'a cost-effective and patient-centric preventive approach' for keratinocyte carcinoma (KC), the study authors reported.

Barcelona Cases Point to an Emerging Transmissible Dermatosis

Ten confirmed cases in Barcelona suggest that a rare skin infection may be spreading through sexual networks, prompting earlier recognition and coordinated surveillance.

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Latest News

Regenxbio said on Monday the U.S. FDA has indicated that existing data for its rare-disease gene therapy could support ⁠an accelerated approval application, reversing course...

Researchers conducted a systematic review of 441 US-based randomized cancer treatment trials to see what patient characteristics were reported.

Inks created with a patient’s own cells may one day help the body regrow tissues.

Psoriasis, hidradenitis suppurativa, alopecia areata, and other skin conditions are more common in people with Down syndrome and require multidisciplinary, mechanism-specific management, experts say.

The study in US veterans found that oral nicotinamide was 'a cost-effective and patient-centric preventive approach' for keratinocyte carcinoma (KC), the study authors reported.

Ten confirmed cases in Barcelona suggest that a rare skin infection may be spreading through sexual networks, prompting earlier recognition and coordinated surveillance.

News All Time

UKHSA: New Pandemic More Than 25% Likely Within 5 Years

Influenza and novel coronavirus top a new UKHSA threat register covering 22 risks, from dengue to drug-resistant infections.

Most OTC Vaginal Moisturizers Contain Contact Allergens

Over-the-counter vaginal and vulvar moisturizers often contain allergens, with inaccurate marketing claims, a study shows.

Takeda's AI-crafted Psoriasis Pill Tops Bristol Myers' Sotyktu in Head-to-head Trial

Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with the help of AI, outperformed Bristol ⁠Myers Squibb's approved drug...

Drop Flare Fears to Fix Rheumatic Vaccination Gaps

Vaccination remains the best measure to protect immunosuppressed patients, but new evidence suggests a rethink of scheduling.

Secondary Syphilis Sign Shows Reliable Histologic Pattern

Condyloma lata in secondary syphilis shows consistent histopathologic findings that may help prevent misdiagnosis.

Can Age-Old Chinese Therapy Reduce Insulin Needs in T2D?

Acupuncture may reduce insulin requirements to a greater extent than a sham treatment in adults with type 2 diabetes and overweight receiving insulin therapy, a trial suggests.

Golimumab Shows Benefit in Refractory HS

More than half of patients with treatment-refractory hidradenitis suppurativa achieve meaningful disease improvement with golimumab therapy in a study.

Psoriasis in Pregnancy: Study Supports Safety of Biologics

In pregnant women with psoriasis, biologic therapy is not linked to increased risk for adverse maternal or neonatal outcomes compared with unexposed patients, study finds.

How Can Canada Improve Access to Dermatologic Care?

The Canadian Dermatology Association proposes increasing residency spots, expanding technology, and integrating international graduates into the workforce.

Choosing a Journal: What Matters More Than Impact Factor?

Researchers weigh peer review, indexing, transparency, and audience reach alongside impact factor when deciding where to submit scientific work.

Bimekizumab Gives Lasting Symptom Relief in PsA

In patients with psoriatic arthritis, long-term bimekizumab treatment shows sustained improvement in symptoms and disease impact, according to an analysis of data from two phase 3 trials.

MHRA Isotretinoin Rules Wasted 12,000 Hours, Analysis Finds

Isotretinoin rules imposed over psychiatric concerns cost the NHS up to £1.4 million in wasted clinical time, dermatologists calculate.

Dr. Bolu Ogunyemi Becomes New CMA President

Bolu Ogunyemi, MD, dermatologist from St. John’s, Newfoundland and Labrador, has become the Canadian Medical Association’s first Black president and is among its youngest.

Pictogram Decision Aid Tool Improves HCQ Adherence in Lupus

A pictogram-based shared decision-making tool improves hydroxychloroquine adherence and reduces decisional conflicts in patients with SLE while requiring less time to deliver.

Can Oral Icotrokinra Relieve High-Impact Site Psoriasis?

Icotrokinra yields high clearance and durable response rates at high-impact sites in patients with psoriasis, with no added adverse events compared with placebo, a 1-year assessment of a trial shows.

Durable Benefit Seen With Personalized Melanoma Vaccine

For patients with high-risk resected melanoma, adding the mRNA vaccine intismeran to pembrolizumab continued to stave off recurrence and distant metastases at 5 years.

Recommended News For You

Using AI, one can find cancer risk factors.

Scientists pioneer noninvasive 3D imaging to enhance skin cancer management

Chromatin organization linked to p53 tumor suppression mechanism

What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care

Research identifies nearly 200 potential breast carcinogens in food packaging materials

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC

The risk of lung cancer recurrence is linked to hypoxemia brought on by sleep apnea.

Recommended Articles For You

Oncologic Emergencies: Diagnosis and Treatment 

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor 

The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond 

Unlocking the Mysteries of the Axillary Vein: Exploring its Role in Human Anatomy 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.

2.

Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival

3.

CAR T cells improve patients' quality of life: a study

4.

No increased risk of childhood cancer near UK nuclear sites, study finds

5.

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

1.

Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges

2.

Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy

3.

Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients

4.

Dexamethasone and Life Expectancy After Pediatric Stem Cell Transplant

5.

Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

3.

Navigating the Complexities of Ph Negative ALL - Part XV

4.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

5.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot